B. Vaughan Hudson

Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study

ME Hill, KA MacLennan, David Cunningham et al. · Blood · 1996 · 312 citations · Full text

Medicine, Oncology, Pathology +8

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.

Anthony J. Swerdlow, A. J. Douglas, G. Vaughan Hudson et al. · BMJ · 1992 · 244 citations · Full text

Medicine, Oncology, Pathology +15

REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEX

J. L. Haybittle, M.J. Easterling, MR Bennett et al. · The Lancet · 1985 · 183 citations

Medicine, Oncology, Pathology +7

Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy

B. Vaughan Hudson, G. Vaughan Hudson, KA MacLennan et al. · British Journal of Cancer · 1994 · 175 citations · Full text

Medicine, Oncology, Radiation Oncology +9

Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients

Kenneth MacLennan, Michael H. Bennett, Anna Tu et al. · Cancer · 1989 · 166 citations

Medicine, Oncology, Pathology +14